Safety of tiotropium Respimat ® in black or African-American patients with symptomatic asthma

This study aimed to assess the safety of tiotropium Respimat®, compared with placebo, in black or Afric an-American patients.

Source: Respiratory Medicine - July 1, 2019 Category: Respiratory Medicine Authors: LeRoy M. Graham, Huib A.M. Kerstjens, Christian Vogelberg, Eckard Hamelmann, Stanley J. Szefler, Wendelgard Pisternick-Ruf, Michael Engel, Georges El Azzi, Anna Unseld, Michael B. Foggs Tags: Short communication Source Type: research